Edwards Lifesciences Corp [NYSE: EW] traded at a high on Friday, posting a 0.57 gain after which it closed the day’ session at $68.52.
The results of the trading session contributed to over 11215620 shares changing hands. Over the past one week, the price volatility of Edwards Lifesciences Corp stands at 3.11% while the volatility over the past one month is 2.86%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for EW stock reached $41.28 billion, with 601.10 million shares outstanding and 592.02 million shares in the current float. Compared to the average trading volume of 5.63M shares, EW reached a trading volume of 11215620 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Edwards Lifesciences Corp [EW]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EW shares is $78.40 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EW stock is a recommendation set at 2.24. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Daiwa Securities have made an estimate for Edwards Lifesciences Corp shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on July 31, 2024. The new note on the price target was released on July 29, 2024, representing the official price target for Edwards Lifesciences Corp stock. Previously, the target price had yet another drop from $110 to $82, while Truist kept a Hold rating on EW stock. On July 25, 2024, analysts decreased their price target for EW shares from 100 to 70.
The Average True Range (ATR) for Edwards Lifesciences Corp is set at 2.20, with the Price to Sales ratio for EW stock in the period of the last 12 months amounting to 6.88. The Price to Book ratio for the last quarter was 5.55, with the Price to Cash per share for the same quarter was set at 3.31. Price to Free Cash Flow for EW in the course of the last twelve months was 72.19 with Quick ratio for the last quarter at 2.87.
How has EW stock performed recently?
Edwards Lifesciences Corp [EW] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.56. With this latest performance, EW shares gained by 3.04% in over the last four-week period, additionally sinking by -26.61% over the last 6 months – not to mention a drop of -6.36% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EW stock in for the last two-week period is set at 47.97, with the RSI for the last a single of trading hit 52.06, and the three-weeks RSI is set at 45.11 for Edwards Lifesciences Corp [EW]. The present Moving Average for the last 50 days of trading for this stock 72.83, while it was recorded at 67.55 for the last single week of trading, and 81.43 for the last 200 days.
Edwards Lifesciences Corp [EW]: Deeper insight into the fundamentals
Edwards Lifesciences Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.87 and a Current Ratio set at 3.71.
Earnings analysis for Edwards Lifesciences Corp [EW]
With the latest financial reports released by the company, Edwards Lifesciences Corp posted 0.59/share EPS, while the average EPS was predicted by analysts to be reported at 0.59/share. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EW. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Edwards Lifesciences Corp go to 7.89%.
Insider trade positions for Edwards Lifesciences Corp [EW]
There are presently around $85.71%, or 86.49%% of EW stock, in the hands of institutional investors. The top three institutional holders of EW stocks are: VANGUARD GROUP INC with ownership of 53.58 million shares, which is approximately 8.9056%. BLACKROCK INC., holding 50.98 million shares of the stock with an approximate value of $$4.71 billion in EW stocks shares; and BLACKROCK INC., currently with $$2.4 billion in EW stock with ownership which is approximately 4.3233%.
